Methamphetamine stimulates interferon inducible genes in HIV infected brain

Journal of Neuroimmunology

Volumn 170, Issue 1-2, 2005, Pages 158-171

  Everall, Ian ^a   Salaria, Shahid ^d   Roberts, Eleanor ^b   Corbeil, Jacques ^c   Sasik, Roman ^d   Fox, Howard ^b   Grant, Igor ^d   Masliah, Eliezer ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c LAVAL UNIVERSITY   (Canada)

^d NONE

Author keywords

Brain; Gene expression; HIV encephalitis; Interferon inducible; Methamphetamine

Indexed keywords

INTERFERON; METHAMPHETAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE LEVEL; UNINDEXED SEQUENCE; UPREGULATION; VIRUS ENCEPHALITIS;

ADULT; BRAIN; COMPUTER SYSTEMS; ENCEPHALITIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERONS; MALE; METHAMPHETAMINE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 28544433521     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.09.009     Document Type: Article

References (54)

1. O. Acikgoz, S. Gonenc, B.M. Kayatekin, N. Uysal, C. Pekcetin, I. Semin, and A. Gure Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum Brain Res. 813 1998 200 202
2. O. Acikgoz, S. Gonenc, B.M. Kayatekin, C. Pekcetin, N. Uysal, A. Dayi, I. Semin, and A. Gure The effects of single dose of methamphetamine on lipid peroxidation levels in the rat striatum and prefrontal cortex Eur. Neuropsychopharmacol. 10 2000 415 418
3. O. Acikgoz, S. Gonenc, S. Gezer, B.M. Kayatekin, N. Uysal, I. Semin, and A. Gure Methamphetamine causes depletion of glutathione and an increase in oxidized glutathione in the rat striatum and prefrontal cortex Neurotox. Res. 3 2001 277 280
4. E. Asare, G. Dunn, J. Glass, J. McArthur, P. Luthert, P. Lantos, and I. Everall Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies Am. J. Pathol. 148 1996 31 38
5. H. Budka, C.A. Wiley, P. Kleihues, J. Artigas, A.K. Asbury, E.S. Cho, D.R. Cornblath, M.C. Dal Canto, U. DeGirolami, and D. Dickson HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology Brain Pathol. 1 1991 143 152
6. M.A. Chesney, D.C. Barrett, and R. Stall Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men Am. J. Public Health 88 1998 113 116
7. M.T. Corasaniti, S. Piccirilli, A. Paoletti, R. Nistico, A. Stringaro, W. Malorni, A. Finazzi-Agro, and G. Bagetta Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor Neurosci. Lett. 312 2001 67 70
8. C. Davidson, A.J. Gow, T.H. Lee, and E.H. Ellinwood Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment Brain Res. Brain Res. Rev. 36 2001 1 22
9. E.J. Duh, W.J. Maury, T.M. Folks, A.S. Fauci, and A.B. Rabson Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat Proc. Natl. Acad. Sci. U. S. A. 86 1989 5974 5978
10. F. Ensoli, V. Fiorelli, M. DeCristofaro, M.D. Santini, A. Novi, B. Vannelli, C.J. Thiele, G. Luzi, and F. Aiuti Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons J. Immunol. 162 1999 6268 6277
11. I.P. Everall, P.J. Luthert, and P.L. Lantos Neuronal loss in the frontal cortex in HIV infection Lancet 337 1991 1119 1121
12. I.P. Everall, P.J. Luthert, and P.L. Lantos Neuronal number and volume alterations in the neocortex of HIV infected individuals J. Neurol. Neurosurg. Psychiatry 56 1993 481 486
13. I.P. Everall, R.K. Heaton, T.D. Marcotte, R.J. Ellis, J.A. McCutchan, J.H. Atkinson, I. Grant, M. Mallory, and E. Masliah Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center Brain Pathol. 9 1999 209 217
14. D. Farabee, M. Prendergast, and J. Cartier Methamphetamine use and HIV risk among substance-abusing offenders in California J. Psychoact. Drugs 34 2002 295 300
15. S.M. Fine, R.A. Angel, S.W. Perry, L.G. Epstein, J.D. Rothstein, S. Dewhurst, and H.A. Gelbard Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia J. Biol. Chem. 271 1996 15303 15306
16. H. Funakoshi, T. Yonemasu, T. Nakano, K. Matumoto, and T. Nakamura Identification of Gas6, a putative ligand for Sky and Axl receptor tyrosine kinases, as a novel neurotrophic factor for hippocampal neurons J. Neurosci. Res. 68 2002 150 160
17. D. Galey, K. Becker, N. Haughey, A. Kalehua, D. Taub, J. Woodward, M.P. Mattson, and A. Nath Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes J. Neurovirology 9 2003 358 371
18. D.R. Gibson, M.H. Leamon, and N. Flynn Epidemiology and public health consequences of methamphetamine use in California's Central Valley J. Psychoact. Drugs 34 2002 313 319
19. J. Gurwell, A. Nath, Q. Sun, J. Zhang, K. Martin, Y. Chen, and K. Hauser Synergistic neurotoxicity of opiods and human immunodeficiency virus-1 tat protein in striatal neurons in vitro Neuroscience 102 2001 555 563
20. G.R. Hanson, K.S. Rau, and A.E. Fleckenstein The methamphetamine experience: a NIDA partnership Neuropharmacology 47 2004 92 100
21. C. Harold, T. Wallace, R. Friedman, G. Gudelsky, and B. Yamamoto Methamphetamine selectively alters brain glutathione Eur. J. Pharmacol. 400 2000 99 102
22. D. Langford, A. Adame, A. Grigorian, I. Grant, J.A. McCutchan, R.J. Ellis, T.D. Marcotte, and E. Masliah Patterns of selective neuronal damage in methamphetamine-user AIDS patients J. Acquir. Immune Defic. Syndr. 34 2003 467 474
23. Y.W. Lee, K.W. Son, G. Flora, B. Hennig, A. Nath, and M. Toborek Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain J. Neurosci. Res. 70 2002 82 89
24. S.A. Lipton, N.J. Sucher, P.K. Kaiser, and E.B. Dreyer Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity Neuron 7 1991 111 118
25. J. Lozach, S.R., S. Ogawa, and C.K. Glass MADCAP: microarray data characterization and profiling. A tool for profiling lists of genes with different expression patterns European Conference on Computational Biology, Paris 2003 GE24
26. M.P. Malakhov, O.A. Malakhova, K.I. Kim, K.J. Ritchie, and D.E. Zhang UBP43 (USP18) specifically removes ISG15 from conjugated proteins J. Biol. Chem. 277 2002 9976 9981
27. M.P. Malakhov, K.I. Kim, O.A. Malakhova, B.S. Jacobs, E.C. Borden, and D.E. Zhang High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction J. Biol. Chem. 278 2003 16608 16613
28. O. Malakhova, M. Malakhov, C. Hetherington, and D.E. Zhang Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3 J. Biol. Chem. 277 2002 14703 14711
29. O.A. Malakhova, M. Yan, M.P. Malakhov, Y. Yuan, K.J. Ritchie, K.I. Kim, L.F. Peterson, K. Shuai, and D.E. Zhang Protein ISGylation modulates the JAK-STAT signaling pathway Genes Dev. 17 2003 455 460
30. W. Maragos, K. Young, J. Turchan, M. Guseva, J. Pauly, A. Nath, and W. Cass Human immunodeficiency virus tat-1 protein and methamphetamine interact synergistically to impair striatal dopaminergic function J. Neurochem. 83 2002 955 963
31. J.F. Marshall, S.J. O'Dell, and F.B. Weihmuller Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity J. Neural Transm. Gen. Sect. 91 1993 241 254
32. E. Masliah, R.K. Heaton, T.D. Marcotte, R.J. Ellis, C.A. Wiley, M. Mallory, C.L. Achim, J.A. McCutchan, J.A. Nelson, J.H. Atkinson, and I. Grant Dendritic injury is a pathological substrate for Human Immunodeficiency Virus-related cognitive disorders Ann. Neurol. 42 1997 963 972
33. E. Masliah, E.S. Roberts, D. Langford, I. Everall, L. Crews, A. Adame, E. Rockenstein, and H.S. Fox Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis J. Neuroimmunol. 157 1-2 2004 163 175 (Dec.)
34. A. Mirecki, P. Fitzmaurice, L. Ang, K.S. Kalasinsky, F.J. Peretti, S.S. Aiken, D.J. Wickham, A. Sherwin, J.N. Nobrega, H.J. Forman, and S.J. Kish Brain antioxidant systems in human methamphetamine users J. Neurochem. 89 2004 1396 1408
35. A. Nath, K. Conant, P. Chen, C. Scott, and E.O. Major Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon J. Biol. Chem. 274 1999 17098 17102
36. A. Nath, C. Anderson, M. Jones, W. Maragos, R. Booze, C. Mactutus, J. Bell, K.F. Hauser, and M. Mattson Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia J. Psychopharmacol. 14 2000 222 227
37. A. Nath, N.J. Haughey, M. Jones, C. Anderson, J.E. Bell, and J.D. Geiger Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine Ann. Neurol. 47 2000 186 194
38. T. Ohmori, T. Abekawa, and T. Koyama The role of glutamate in the neurotoxic effects of methamphetamine Ann. N. Y. Acad. Sci. 801 1996 315 326
39. G.A. Ricaurte, J. Yuan, G. Hatzidimitriou, B.J. Cord, and U.D. McCann Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy") Science 297 2002 2260 2263
40. K.J. Ritchie, M.P. Malakhov, C.J. Hetherington, L. Zhou, M.T. Little, O.A. Malakhova, J.C. Sipe, S.H. Orkin, and D.E. Zhang Dysregulation of protein modification by ISG15 results in brain cell injury Genes Dev. 16 2002 2207 2212
41. E.S. Roberts, M.A. Zandonatti, D.D. Watry, L.J. Madden, S.J. Henriksen, M.A. Taffe, and H.S. Fox Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS Am. J. Pathol. 162 2003 2041 2057
42. R. Sasik, E. Calvo, and J. Corbeil Statistical analysis of high-density oligonucleotide arrays: a multiplicative noise model Bioinformatics 18 2002 1633 1640
43. S.L. Shankar, K. O'Guin, M. Cammer, F.A. McMorris, T.N. Stitt, R.S. Basch, B. Varnum, and B. Shafit-Zagardo The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway J. Neurosci. 23 2003 4208 4218
44. D. Sheeter, P. Du, S. Rought, D. Richman, and J. Corbeil Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infection AIDS Res. Hum. Retrovir. 19 2003 117 123
45. G.R. Stark, I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Ann. Rev. Biochem. 67 1998 227 264
46. Z.Z. Su, D.C. Kang, Y. Chen, O. Pekarskaya, W. Chao, D.J. Volsky, and P.B. Fisher Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH Oncogene 21 2002 3592 3602
47. Z.Z. Su, D.C. Kang, Y. Chen, O. Pekarskaya, W. Chao, D.J. Volsky, and P.B. Fisher Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization J. Neurovirol. 9 2003 372 389
48. M. Tardieu Mechanisms of macrophage-mediated neurotoxicity H.E. Gendelman I. Grant I.P. Everall S. Lipton S. Swindells Tha Neurology of AIDS 2004 Oxford University Press Oxford
49. G. Trillo-Pazos, E. McFarlane-Abdulla, I.C. Campbell, G.J. Pilkington, and I.P. Everall Recombinant nef HIV-IIIB protein is toxic to human neurons in culture Brain Res. 864 2000 315 326
50. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, J. Logan, C. Wong, and E.N. Miller Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am. J. Psychiatry 158 2001 377 382
51. J.P. Wang, S.E. Rought, J. Corbeil, and D.G. Guiney Gene expression profiling detects patterns of human macrophage responses following Mycobacterium tuberculosis infection FEMS Immunol. Med. Microbiol. 39 2003 163 172
52. Y. Xu, J. Kulkosky, E. Acheampong, G. Nunnari, J. Sullivan, and R.J. Pomerantz HIV-1-mediated apoptosis of neuronal cells: proximal molecular mechanisms of HIV-1-induced encephalopathy Proc. Natl. Acad. Sci. U. S. A. 101 2004 7070 7075
53. T. Yagami, K. Ueda, K. Asakura, T. Sakaeda, H. Nakazato, T. Kuroda, S. Hata, G. Sakaguchi, N. Itoh, T. Nakano, Y. Kambayashi, and H. Tsuzuki Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis Neuropharmacology 43 2002 1289 1296
54. Q. Yu, D. Zhang, M. Walston, J. Zhang, Y. Liu, and R.R. Watson Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice Int. Immunopharmacol. 2 2002 951 962